Stock Option

OliX Pharmaceuticals, Inc.

226950·KOSDAQ·23 grantsAmendments merged

Shares granted, cumulative
869,490shares
Next lockup release
D-222
2027-03-29

Against the share price

At the 2026-08-18 close
KRW
-4.91%
Shares with a reason to exercise
646,490 shares
3.07% of shares outstanding
Sellable right now
253,490 shares
39% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩43.9B

Potential dilution

4.13%Against the 15% cap

Shares by strike price

  • ₩164.6K–₩178.3K123K shares
  • ₩137.2K–₩150.9K60K shares
  • ₩106,500Latest price
  • ₩82.4K–₩96.1K55K shares
  • ₩55K–₩68.7K30K shares
  • ₩41.3K–₩55K220K shares
  • ₩27.6K–₩41.3K60K shares
  • ₩13.9K–₩27.6K282K shares

Below the line (strike < Latest price) sits above the strike price: 646K shares, 78% of the shares still inside their exercise window.

Exercise deadline within a yearD-212Earliest deadline 2027-03-19

The paper gain on 55,000 shares sitting above the strike price — ₩3B — disappears unless they are exercised by the deadline. Among the options whose lockup has ended, this is the part whose timing is pinned down.

See every approaching deadline

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩106,5002025-08-14 ~ 2026-08-18
  • Strike ₩50,000175K sharesabove
  • Strike ₩16,750134K sharesabove
  • Strike ₩178,300123K shares
  • Strike ₩22,30080K sharesabove

Recipients by role

869KShares granted
  • Registered director3 people7%
  • Unregistered officer21 people50%
  • Employee102 people35%
  • Other · unknown7 people9%

Sorted from the relation text written in the filings (133 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers.

Shares granted by year

40K
64K
75K
15K
20K
80K
134K
260K
183K
'18
'19
'20
'21
'22
'23
'24
'25
'26

Cumulative grants per recipient

21 named · 102 withheld
Largest holder강충길Registered director
Top holder 9.2%Top 3 25.2%
RecipientShares, cumulativePaper gain
80,0009.2%₩3.6B
79,0009.1%₩4.3B
60,0006.9%₩3.5B
40,0004.6%₩3.1B
40,0004.6%—
30,0003.5%₩1.2B
30,0003.5%₩1.7B
30,0003.5%₩1.7B
30,0003.5%₩603M
30,0003.5%—

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.